The hepatitis C infection rate among young people increased more than threefold from 2006 to 2012 in Kentucky, Tennessee, Virginia and West Virginia, according to a study by the CDC. A majority of people with new cases reported abusing injectable opioid drugs. Nationally, the rate of hepatitis C infection more than doubled from 2010 to 2013.
The U.K.'s National Institute for Health and Care Excellence released final guidelines endorsing the use of hepatitis C drugs Sovaldi, or sofosbuvir, from Gilead Sciences and Olysio, or simeprevir, from Janssen. Sovaldi was recommended to use in combination with other therapies to treat chronic hepatitis C patients with genotypes 1 to 6 infection, while Olysio was endorsed for use as a treatment option for HCV patients with genotypes 1 and 4 infection.
Bristol-Myers Squibb's combination of daclatasvir and asunaprevir has received approval from the Japanese Ministry of Health, Labor and Welfare for the treatment of genotype 1 chronic hepatitis C virus infections that cannot be treated with interferon. The approval was based on positive data from a Phase III study.
National Wildlife Health Center officials have confirmed that infected grebes were the source of West Nile virus infection among more than 50 bald eagles that died of the disease in Utah. Four surviving birds are currently being rehabilitated.
Children who have inflammatory bowel disease can safely be vaccinated against influenza and should be encouraged to do so, according to researchers from Children's Hospital of Eastern Ontario. The study, which included almost 5,000 children with IBD, found no increase in their use of health services following immunization, when compared with control data.